Who is this course for?
Clinicians and mental health professionals interested in trauma, integrative psychiatry, and psychedelic-assisted treatment.
Dr. Sidney Edsall is an integrative psychiatrist with experience in trauma, ketamine-assisted psychotherapy, and psychedelic medicine research. Her background includes clinical work in integrative and hospital settings, as well as trials involving 5-MeO-DMT, psilocybin, and MDMA-assisted psychotherapy.
Dr. Sidney Edsall is an integrative psychiatrist whose work focuses on the effects of trauma and how it can appear as psychiatric and medical disorders in individuals. She is the founder and medical director of Quantum Integral Healing Arts, a multidisciplinary mental health clinic in San Francisco that uses ketamine-assisted psychotherapy alongside practices such as acupuncture, meditation, and mindfulness. Her experience includes research and clinical roles in psychedelic medicine, including service as lead therapist for a Phase 3 clinical trial of 5-MeO-DMT for treatment-resistant depression, co-principal investigator for a Phase 3 psilocybin trial for Major Depressive Disorder, and study physician for MAPS Phase 2 and 3 MDMA-assisted psychotherapy trials for PTSD. She has also worked in several clinical settings since completing psychiatric residency at Stanford in 2006, including UCSF Weill Institute for Neurosciences, St. Mary’s Hospital & Clinics in San Francisco, Stanford’s Center for Integrative Medicine, and on U.S. military bases in Italy and Germany. Her background is relevant to clinicians and mental health professionals interested in trauma, integrative psychiatry, and psychedelic-assisted treatment.
Clinicians and mental health professionals interested in trauma, integrative psychiatry, and psychedelic-assisted treatment.
Alchemy Community Therapy Center is a nonprofit, sliding-scale mental health clinic and training centre in Oakland, California. It provides equitable psychedelic-assisted psychotherapy and offers training for therapists, including a two-year associateship programme and a ketamine-assisted therapy provider training. The organisation says it was founded in 2019 to address inequities in access to psychedelic-assisted therapy.
View all Alchemy coursesClinicians and mental health professionals interested in trauma, integrative psychiatry, and psychedelic-assisted treatment.
Time commitment: 5 years.
This listing does not have a public price yet. Check the provider website for current tuition, fees, or application-based pricing.
The current listing status is No New Dates. Use the provider website for the latest enrollment status.
By AWE
Shares course skills and categories
AWE's Ecstatic Mysticism programme offers two- or three-year experiential training, plus an online-only path, combining online study, retreats, pilgrimages, and supervised integration. Applications are open for the December 2026 intake.
Next cohort: Dec 1, 2026
Source lists: Estimated 930-1400 hours
Delivery: Online + Mexico + Ecuador
Optional medicine self-experience
By CIIS
Shares course skills and categories
A 12-month certificate in psychedelic-assisted therapies and research housed in the CIIS Center for Psychedelic Therapies and Research. The program offers hybrid or online training covering clinical competencies, research, ethics, and culturally informed approaches.
Next cohort: Jul 13, 2026
By SoundMind
Shares course skills and categories
SoundMind Psychedelic Facilitator Training is an 8-month certificate program for Oregon psilocybin facilitator training. It covers psychedelic-assisted therapy topics, including ketamine, psilocybin, and MDMA in therapeutic settings.
Next cohort: Sep 1, 2026
Delivery: Online + United States
Includes medicine self-experience